Study of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced Triple Negative Breast Cancer (TNBC)
Clinical trial NCT03057600 · COMPLETED
Trial details
- NCT number
- NCT03057600
- Sponsor
- Calithera Biosciences, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2019-11-25
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.